Consensus Hims & Hers Health, Inc.

Equities

HIMS

US4330001060

Market Closed - Nyse Other stock markets 04:00:06 2024-05-16 pm EDT			5-day change	1st Jan Change
14.04 ^USD	+1.41%		+8.63%	+57.70%

May. 07	Sector Update: Consumer Stocks Mixed Pre-Bell Tuesday	MT
May. 07	Piper Sandler Adjusts Hims & Hers Health's Price Target to $13 From $11, Keeps Neutral Rating	MT

Evolution of the average Target Price on Hims & Hers Health, Inc.

Price target over the last 5 years

History of analyst recommendation changes

b61f19b98.SIW7STepyqCye4NRM3aIVJyH8-MR0zLHvVRgQU5wW0U.ev3ZL07x_s_iKrs2Yj7dJsmqg9dHomquiwUUEwcfDHYKy_Axe8O7wusK5A~fd348ddb799f16984558d699f94ac791

Analyst Recommendations on Hims & Hers Health, Inc.

Piper Sandler Adjusts Hims & Hers Health's Price Target to $13 From $11, Keeps Neutral Rating	May. 07	MT
Deutsche Bank Adjusts Hims & Hers Health Price Target to $16 From $14, Maintains Hold Rating	May. 07	MT
Social Buzz: Wallstreetbets Stocks Mixed Pre-Bell Monday; Palantir to Advance, Trump Media & Technology Group to Decline	May. 06	MT
Hims & Hers Health Insider Sold Shares Worth $4,200,307, According to a Recent SEC Filing	May. 06	MT
Seaport Global Starts Hims & Hers Health With Buy Rating	Apr. 26	MT
Jefferies Downgrades Hims & Hers Health to Hold From Buy, Cuts Price Target to $15 From $17	Apr. 16	MT
Canaccord Genuity Initiates Coverage on Hims & Hers Health With Buy Rating, $20 Price Target	Apr. 10	MT
Hims & Hers Health Insider Sold Shares Worth $823,055, According to a Recent SEC Filing	Mar. 22	MT
Tigress Financial Boosts Price Target on Hims & Hers Health to $19 From $15, Cites Move to Accelerated Growth Phase, Keeps Buy Rating	Mar. 01	MT
Piper Sandler Adjusts Price Target on Hims & Hers Health to $11 From $9, Maintains Neutral Rating	Feb. 27	MT
Deutsche Bank Adjusts Hims & Hers Health Price Target to $14 From $8, Maintains Hold Rating	Feb. 27	MT
Truist Securities Adjusts Price Target on Hims & Hers Health to $13 From $10, Keeps Hold Rating	Feb. 27	MT
Leerink Partners Initiates Coverage on Hims & Hers Health With Market Perform Rating, $10 Price Target	Feb. 26	MT
Tigress Financial Raises Price Target on Hims & Hers Health to $15 From $14, Maintains Buy Rating	Jan. 05	MT
Deutsche Bank Adjusts Hims & Hers Health Price Target to $8 From $11, Maintains Hold Rating	Nov. 08	MT
Truist Securities Cuts Price Target on Hims & Hers Health to $10 From $12, Maintains Hold Rating	23-08-09	MT
TD Cowen Starts Hims & Hers Health at Outperform With $11 Price Target	23-07-28	MT
Tigress Financial Adjusts Hims & Hers Health Price Target to $14 From $12 Due to Ongoing Growth, Penetration in Core Markets, Maintains Buy Rating	23-06-15	MT
Tigress Financial Adjusts Hims & Hers Health Price Target to $14 From $12, Maintains Buy Rating	23-06-15	MT
Piper Sandler Adjusts Price Target on Hims & Hers Health to $11 From $12, Keeps Neutral Rating	23-05-30	MT
Deutsche Bank Adjusts Hims & Hers Health Price Target to $11 From $9, Maintains Hold Rating	23-05-10	MT
BofA Securities Adjusts Hims & Hers Health's Price Target to $15 From $13.50, Keeps Buy Rating	23-05-09	MT
Piper Sandler Adjusts Price Target on Hims & Hers Health to $12 From $10, Keeps Neutral Rating	23-05-09	MT
Guggenheim Adjusts Price Target on Hims & Hers Health to $18 From $15, Maintains Buy Rating	23-04-27	MT
Baird Initiates Hims & Hers Health at Neutral	23-04-11	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

14.04 USD

Average target price

16.33 USD

Spread / Average Target

+16.29%

High Price Target

24 USD

Spread / Highest target

+70.94%

Low Price Target

13 USD

Spread / Lowest Target

-7.41%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Hims & Hers Health, Inc.

Piper Sandler
Deutsche Bank Securities
Seaport Global Securities
Jefferies & Co.
Canaccord Genuity
Tigress Financial
Truist Securities
Leerink Partners
TD Cowen
BofA Securities
Guggenheim
Baird
Credit Suisse
Citigroup
SVB Securities LLC

Ratings for Hims & Hers Health, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar